These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Gholami M; Amoli MM Genet Test Mol Biomarkers; 2019 Sep; 23(9):696-697. PubMed ID: 31524545 [No Abstract] [Full Text] [Related]
10. Correction to: Genet Test Mol Biomarkers; 2019 Sep; 23(9):700. PubMed ID: 31524542 [No Abstract] [Full Text] [Related]
11. Response to Gholami and Mohammad Amoli: Geng H; Li B; Wang Y; Wang L Genet Test Mol Biomarkers; 2019 Sep; 23(9):698-699. PubMed ID: 31524544 [No Abstract] [Full Text] [Related]
12. Screening of Variations in CD22 Gene in Children with B-Precursor Acute Lymphoblastic Leukemia. Aslar Oner D; Akin DF; Sipahi K; Mumcuoglu M; Ezer U; Kürekci AE; Akar N Genet Test Mol Biomarkers; 2016 Sep; 20(9):552-5. PubMed ID: 27486888 [TBL] [Abstract][Full Text] [Related]
13. Correction to: CRP/IL-6/IL-10 Genet Test Mol Biomarkers; 2019 Jun; 23(6):433. PubMed ID: 31033352 [No Abstract] [Full Text] [Related]
14. Detection of intracellular lymphoid differentiation antigens by flow cytometry in acute lymphoblastic leukemia. Sartor M; Bradstock K Cytometry; 1994 Sep; 18(3):119-22. PubMed ID: 7813331 [TBL] [Abstract][Full Text] [Related]
15. A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer. Jahn L; Hagedoorn RS; van der Steen DM; Hombrink P; Kester MG; Schoonakker MP; de Ridder D; van Veelen PA; Falkenburg JH; Heemskerk MH Oncotarget; 2016 Nov; 7(44):71536-71547. PubMed ID: 27689397 [TBL] [Abstract][Full Text] [Related]
16. Characterization of CD22 expression in acute lymphoblastic leukemia. Shah NN; Stevenson MS; Yuan CM; Richards K; Delbrook C; Kreitman RJ; Pastan I; Wayne AS Pediatr Blood Cancer; 2015 Jun; 62(6):964-9. PubMed ID: 25728039 [TBL] [Abstract][Full Text] [Related]
17. Frequency of thiopurine S-methyltransferase gene variations in Turkish children with acute leukemia. Akın DF; Aşlar-Öner D; Kürekçi E; Akar N Turk J Pediatr; 2018; 60(2):147-152. PubMed ID: 30325120 [TBL] [Abstract][Full Text] [Related]
18. Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Haso W; Lee DW; Shah NN; Stetler-Stevenson M; Yuan CM; Pastan IH; Dimitrov DS; Morgan RA; FitzGerald DJ; Barrett DM; Wayne AS; Mackall CL; Orentas RJ Blood; 2013 Feb; 121(7):1165-74. PubMed ID: 23243285 [TBL] [Abstract][Full Text] [Related]
19. [In vitro studies on the transfer of CAR into leukemia cells due to their residue in the autologous CAR-T cell preparation system for acute B-cell acute lymphoblastic leukemia]. Liu MJ; Mu J; Yuan T; Cui R; Meng JX; Jiang YY; Li YM; Deng Q Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):140-145. PubMed ID: 33858045 [No Abstract] [Full Text] [Related]
20. Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemia. George B; Kantarjian H; Jabbour E; Jain N Immunotherapy; 2016 Feb; 8(2):135-43. PubMed ID: 26780449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]